Option Care Health, Inc. $OPCH Shares Newly Purchased by Prescott Group Capital Management L.L.C.

Prescott Group Capital Management L.L.C. acquired a new position in Option Care Health, Inc. (NASDAQ:OPCH) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 20,000 shares of the company’s stock, valued at approximately $450,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. ARGA Investment Management LP acquired a new stake in shares of Option Care Health during the third quarter worth $2,024,000. Vise Technologies Inc. lifted its holdings in Option Care Health by 88.7% in the third quarter. Vise Technologies Inc. now owns 20,516 shares of the company’s stock valued at $461,000 after buying an additional 9,646 shares during the period. Choreo LLC acquired a new position in Option Care Health in the third quarter valued at $419,000. VestGen Advisors LLC bought a new stake in Option Care Health during the third quarter valued at $220,000. Finally, Leeward Investments LLC MA boosted its position in Option Care Health by 20.1% during the third quarter. Leeward Investments LLC MA now owns 848,059 shares of the company’s stock valued at $19,073,000 after acquiring an additional 142,007 shares during the last quarter. 98.05% of the stock is owned by institutional investors and hedge funds.

Option Care Health Stock Performance

Shares of OPCH opened at $31.77 on Wednesday. The company has a debt-to-equity ratio of 0.91, a quick ratio of 0.98 and a current ratio of 1.47. The stock has a 50 day moving average price of $26.83 and a two-hundred day moving average price of $26.44. The firm has a market capitalization of $4.76 billion, a P/E ratio of 23.89, a P/E/G ratio of 1.93 and a beta of 0.47. Option Care Health, Inc. has a 52 week low of $18.01 and a 52 week high of $36.80.

Analysts Set New Price Targets

A number of analysts have weighed in on OPCH shares. Truist Financial set a $32.05 price target on Option Care Health in a report on Wednesday, October 7th. UBS Group downgraded Option Care Health from a “buy” rating to a “neutral” rating and dropped their price objective for the company from $39.00 to $32.05 in a research note on Friday, October 9th. Deutsche Bank Aktiengesellschaft lowered Option Care Health from a “buy” rating to a “hold” rating and cut their target price for the company from $26.00 to $24.00 in a research report on Thursday, July 30th. JPMorgan Chase & Co. cut Option Care Health from an “overweight” rating to a “neutral” rating and set a $33.00 target price for the company. in a research note on Wednesday, October 7th. Finally, Weiss Ratings upgraded Option Care Health from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, October 20th. Two investment analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $29.48.

About Option Care Health

Option Care Health, Inc is an independent provider of home and alternate-site infusion services in the United States. The company coordinates and delivers infusion therapy outside traditional hospital settings, including patients’ homes, ambulatory infusion suites and other outpatient locations.

Its services include administration of anti-infective therapies, immune globulin, nutrition support, inotropic therapies and medications used in the treatment of chronic and complex conditions.